Maria Sharapova will face an anti-doping panel in London on Wednesday after taking the banned drug Meldonium.
The 29-year-old Russian failed a doping test after the Australian Open in January.
Meldonium, which the Russian said she was using to treat a heart condition, was added to the World Anti-Doping Agency’s banned list on January 1 this year, but Sharapova continued taking the drug past that date as she said she did not know it had been added to the banned substance list.
According to the reports, the International Tennis Federation panel could issue a four-year-ban to the five-time tennis grand slam winner.
(With Agency Inputs)